"The Center for Drug Safety Sciences positions North Carolina to be a leading force in drug safety," said Dr. William Greenlee, president and CEO of The Hamner Institutes. "This partnership with one of the world's leading biomedical research universities will bring together academe, the bio/pharma industry, and government to accelerate the discovery and development of new and safer medicines."
"For many people, life depends on safe, effective drugs," said Dr. Holden Thorp, UNC-Chapel Hill chancellor. "With The Hamner Institutes and our other collaborators, we will use research-based information to enhance drug safety and improve human health. I can't imagine anyone more qualified to lead this vital effort than Paul Watkins."
"Understanding why good drugs are bad for some people has become a national research priority," said Dr. Paul Watkins, director of the Center for Drug Safety Sciences. "I am extremely excited about the opportunity to capitalize on the unique resources and expertise at UNC-Chapel Hill and The Hamner Institutes. The CDSS positions North Carolina to be a global leader in drug safety."
About The Hamner Institutes for Health Sciences:
The Hamner Institutes for Health Sciences is strategically located on a
56-acre campus in the heart of Research Triangle Park, N.C. As a
cross-disciplinary nonprofit organization, The Hamner Institutes acts as a
catalyst to facilitate technology development among North Carolina
universities, while serving as a gateway to establish research
collaborations with the bio/pharmaceutical industry and countries in Europe
and Asia. The Hamner Institutes also has an Accelerator to support emerging
companies and a new Institute for Translational Medicine to enhance its
research in oncology, diabetes, and respiratory diseases. For more
information, visit http://www.thehamner.org .
|SOURCE The Hamner Institutes for Health Sciences|
Copyright©2008 PR Newswire.
All rights reserved